Department of Mechanisms of Antitumor Therapy, R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
Department of Mechanisms of Antitumor Therapy, R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
Department of Mechanisms of Antitumor Therapy, R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
Department of Mechanisms of Antitumor Therapy, R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
Department of Mechanisms of Antitumor Therapy, R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
Department of Mechanisms of Antitumor Therapy, R.E. Kavetsky Institute of Experimental Pathology,
Oncology and Radiobiology, NAS of Ukraine, Kyiv, Ukraine
Copyright © 2013 Vasyl’ Chekhun, Natalia Lukianova, Dmytro Demash, Tetiana Borikun, Svyatoslav Chekhun, Yulia Shvets et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Chekhun, V. , Lukianova, N. , Demash, D. , Borikun, T. , Chekhun, S. and Shvets, Y. (2013) Manifestation of Key Molecular Genetic Markers in Pharmacocorrection of Endogenous Iron Metabolism in MCF-7 and MCF-7/DDP Human Breast Cancer Cells.
CellBio,
2, 217-227. doi:
10.4236/cellbio.2013.24025.